Steroid cream for hand-foot skin reactions from chemo
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether a corticosteroid cream can prevent or reduce hand-foot skin reactions caused by liposomal doxorubicin (a type of chemotherapy) in breast cancer patients. If you are starting this chemo and are concerned about skin side effects, this study may offer a way to manage them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have breast cancer (early or advanced) confirmed by a biopsy.
- You are scheduled to receive a chemo regimen that includes liposomal doxorubicin and cyclophosphamide.
- You are in good general health (able to do daily activities without much help) and have adequate organ function (kidneys, liver, blood counts).
- You have not had liposomal doxorubicin before and are not allergic to doxorubicin or similar products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using cold therapy (cryotherapy) together with compression can lower the chance of numbness, tingling, or pain in the hands and feet caused by chemotherapy. It may help people planning chemotherapy for breast cancer stay more comfortable and function better.
This trial tests if a diclofenac cream can help prevent skin redness, peeling, or pain caused by radiation therapy. It is for people with certain head and neck cancers or breast cancer who are starting radiation treatment.
This trial tests whether a steroid called dexamethasone, given before T-DXd, can reduce the risk of a rare but serious lung side effect (interstitial lung disease) in people with advanced breast cancer. If it works, it may make treatment safer.
This trial tests whether a special cream containing N-acetylcysteine and urea can prevent the painful hand-foot syndrome often caused by the chemotherapy drug capecitabine. If you have breast cancer and are about to start capecitabine, this study may help reduce side effects.
This trial tests a steroid drug combined with standard hormone therapy to see if it can make the cancer respond again. It is for people with hormone receptor positive, HER2 negative breast cancer that has spread and stopped responding to previous hormone treatments.
This study tests whether soaking your hands and feet in a special herbal bath can help relieve nerve pain, tingling, or numbness caused by chemotherapy for breast cancer. It may offer a simple, drug-free way to manage these side effects while you continue your treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.